← Eichor
Condition: Chemotherapy Intolerant Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Chemotherapy Intolerant

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

CHiR Therapy for Elderly DLBCL Intolerant to Chemo
Phase 2 · 1 location(s) · First Affiliated Hospital of Ningbo University · NCT06764017Clinical Study of HiR+X Therapy for Newly Diagnosed Elderly Patients With DLBCL Intolerant to Chemotherapy
Phase 2 · 1 location(s) · First Affiliated Hospital of Ningbo University · NCT06758037Nelmastobart in Combination With Docetaxel in Non Small Cell Lung Cancer
Phase 2 · 5 location(s) · STCube, Inc. · NCT07306624Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer
EARLY_Phase 1 · 1 location(s) · Ruijin Hospital · NCT06496373A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Che
Phase 3 · 166 location(s) · Jazz Pharmaceuticals · NCT06435429
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.